Business Categories Reports Podcasts Events Awards Webinars
Contact My Account About
Member Exclusive

P&G Agrees to Buy Thorne for $3.8 Billion

Published August 5, 2026
Published August 5, 2026
Thorne

Key Takeaways:

  • P&G to acquire Thorne, beating out Unilever and Haleon. 
  • The deal would represent a strong return on investment of more than $3 billion for L Catterton.
  • Earlier this year, P&G acquired clean health startup Wonderbelly for an undisclosed sum.

Procter & Gamble won the bidding war for supplement maker Thorne.

WHO: Founded in 1984, Thorne is a leader in developing innovative solutions for delivering personalized approaches to health and wellness. As a science-driven wellness company, Thorne empowers individuals with the support, education, and solutions they need to achieve healthy aging—living healthier longer. Thorne uses testing and data to improve product efficacy and deliver personalized solutions to consumers, health professionals, and corporations. Predicated on the power of the individual, Thorne leverages artificial intelligence models to provide insights and personalized data, products, and services that help individuals take a proactive and actionable approach to improve and maintain their health over their lifetime. Thorne is the only supplement manufacturer that collaborates with Mayo Clinic on health and wellness research and content, and is trusted by more than five million customers, 47,000+ healthcare professionals, and thousands of professional athletes.

L Catterton is the largest global consumer-focused investment firm managing approximately $40 billion of equity capital across multiproduct platforms dedicated to private equity, credit, and real estate. The firm's funds can invest between $5 million and $5 billion across the capital structure in well-positioned consumer businesses.

×

1 Article(s) Remaining

Subscribe today for full access